Schedule H and Schedule H1 Drugs in India: What Export Buyers Need to Know
If you are sourcing pharmaceutical products from India, you will frequently encounter references to "Schedule H" and "Schedule H1" on product labels and in regulatory conversations. These classifications — defined under the Drugs & Cosmetics Rules, 1945 — indicate the prescribing and dispensing controls that apply to a product in the Indian market.
Understanding what these schedules mean helps you ask better questions of your supplier and manage your import documentation more effectively.
This post is an educational overview for trade purposes. For regulatory advice specific to your country's import requirements, consult a qualified regulatory affairs professional.---
India's Drug Scheduling System: Overview
The Drugs & Cosmetics Rules, 1945, maintain a series of Schedules that classify drugs according to the controls applied to their manufacture, sale, distribution, and dispensing. The schedules most relevant to import buyers of prescription medicines are:
- Schedule H: General prescription-only medicines - Schedule H1: An enhanced-control subcategory introduced in 2013, covering specified antibiotics and other drugs of public health concern - Schedule X: Controlled substances with stricter prescribing and record-keeping requirements (not addressed in detail here)
---
Schedule H: Prescription-Only Medicines
Schedule H of the Drugs Rules lists medicines that may only be sold in India on a valid prescription from a Registered Medical Practitioner (RMP). The list includes a large portion of commonly traded pharmaceutical products — antibiotics, antivirals, cardiovascular drugs, and many others.
What Schedule H means on a label: - The label must display: "Schedule H drug — Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only" - The "Rx" symbol must appear - A wholesale dealer may supply Schedule H drugs only to another licensed dealer or against a valid prescription What this means for export buyers: Schedule H is a domestic Indian market control — it governs how the product is sold within India. For export, the product must still comply with Indian export regulations (including relevant CDSCO export provisions), but your import country will apply its own classification and prescribing controls, which may or may not mirror India's Schedule H list.From a documentation perspective, the Schedule H classification on the label confirms you are dealing with a product that is classified as prescription-only in India — relevant background when preparing your import dossier and navigating your own country's import classification.
---
Schedule H1: Enhanced Controls on Priority Medicines
Schedule H1 was introduced via an amendment to the Drugs Rules in 2013, responding to concerns about antibiotic resistance and overuse of certain high-risk medicines. Schedule H1 adds a layer of control on top of Schedule H, specifically for:
- Third- and fourth-generation cephalosporins and carbapenems - Fluoroquinolones (certain agents) - Certain antifungals, antivirals, and other specified medicines - Habit-forming medicines
(The full Schedule H1 list is maintained by CDSCO and was last updated through the Drugs and Cosmetics (Fifth Amendment) Rules, 2013 and subsequent notifications — buyers should check the current official CDSCO-published list for the most up-to-date classification.) Additional requirements for Schedule H1: - Labels must display a distinctive red vertical line on the outer packaging (to signal enhanced control) - Retailers must record the prescription details in a register — name, address, prescriber name, licence number, date, quantity dispensed - Sellers must maintain records of all Schedule H1 transactions for prescribed periods What this means for export buyers: If you are sourcing molecules that fall under Schedule H1 in India, the supplier will have more rigorous record-keeping obligations domestically. For export, the documentation trail (batch records, sale records) may be more robust — which is generally beneficial for import compliance.---
Why Schedule Classification Matters in Export Procurement
When procuring prescription medicines from India for export:
1. Label verification: Check that Schedule H / H1 designations are correctly marked on domestic-market product. For export-labelled product, the domestic Indian schedule may not appear (the label will be formatted to importing-country requirements), but the manufacturer's batch documentation will reflect the domestic classification.
2. Documentation completeness: Schedule H and H1 products will have domestic transaction records tracing from manufacturer through wholesale chain — useful if your import authority requests supply-chain traceability evidence.
3. Implication for your country's classification: Your regulatory authority has its own classification system. A Schedule H drug in India may be classified differently in your market. Your local regulatory consultant can map Indian Schedule H products to your country's import category — do not assume the classifications are equivalent.
4. Controlled substances (Schedule X and beyond): This post has not addressed Schedule X or narcotics/psychotropic substances, which have substantially different procurement, documentation, and export control requirements. Buyers with interest in such products should seek specialist regulatory advice specific to both Indian export requirements and the target country's import controls.
---
Practical Checklist for Schedule H / H1 Product Procurement
- Confirm the molecule's Indian schedule classification (CDSCO schedules are publicly available) - Verify your supplier holds a drug license covering wholesale of scheduled medicines - Request batch CoA and manufacturer's batch manufacturing record availability - Confirm how your country classifies the same molecule for import purposes - Work with a local regulatory affairs consultant for product registration requirements
---
Questions about product schedules, documentation requirements, or procurement process for Indian pharmaceuticals? Contact Bharat Medex — we are happy to discuss your specific product requirements.
0 comments